ConferencePoster
 (2025)

Preclinical mechanistic PK/PD-efficacy modeling for AZD9750, a novel oral androgen receptor degrader (PROTAC), to support dose selection during early clinical development

Pablo Morentin Gutierrez; Ana Quiroga Campano; Antonio Ramos Montoya; Claire Crafter; Chrysiis Michaloglou; Aaron Smith; Nuria Galeano Dalmau; Jamie Scott; Michael Niedbala